New Study Suggests HIV-Prevention Pill May Be 100% Effective

 

Researchers working with 600 people who use the HIV prevention pill Truvada have just revealed their striking results: after more than two-and-a-half years, no new HIV infections have been detected. The work was published in Clinical Infectious Diseases this week.

The daily pill Truvada is what’s known as an HIV pre-exposure prophylaxis (PrEP). Green-lit by the U.S. Food and Drug Administration in July 2012, it’s the first drug approved that reduces the risk of infection in uninfected individuals who may engage in sexual activity with HIV-infected partners. When the person is exposed to HIV, two anti-retroviral medicines (called tenofovir and emtricitabine) contained within the pill work to keep the virus from establishing a permanent infection when taken consistently, according to the Centers for Disease Control and Prevention.

Read more: http://www.iflscience.com/health-and-medicine/new-study-suggests-hiv-prevention-pill-may-be-100-effective